Actovegin (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Actovegin" in English language version.

refsWebsite

Global rank English rank

13nih.gov

4^th place

11doi.org

2^nd place

5semanticscholar.org

11^th place

8^th place

2spiegel.de

66^th place

350^th place

2espn.com

56^th place

42^nd place

2nytimes.com

7^th place

1webmd.com

1,169^th place

1,075^th place

1nydailynews.com

134^th place

100^th place

1safemedicines.org

low place

1cbsnews.com

108^th place

80^th place

1latimes.com

22^nd place

19^th place

1cyclingtips.com

low place

1dailynews.com

1,857^th place

1,076^th place

1newswire.com

low place

1docs.google.com

1,047^th place

1,015^th place

1thepharmaletter.com

low place

1nycomed.com

low place

1d-nb.info

511^th place

7,028^th place

cbsnews.com

"Former Pro Cyclist Pleads Guilty To Importing, Selling Performance Enhancing Drugs". www.cbsnews.com. 16 March 2016. Retrieved 2023-03-01.

cyclingtips.com

Flax, Peter (2016-03-28). "Who is Thorfinn-Sassquatch? The mysterious case of a Los Angeles Strava legend". CyclingTips. Retrieved 2023-03-01.

d-nb.info

"Comprehensive Analytics of Actovegin® and Its Effect on Muscle Cells". 11 September 2017. {{cite journal}}: Cite journal requires |journal= (help)

dailynews.com

"L.A. cyclist who sold performance-enhancing drugs to be sentenced today". Daily News. 2016-07-20. Retrieved 2023-03-01.

docs.google.com

USADA v. Armstrong, Reasoned decision, section IV B 3.e (pp. 42–45) (USADA 10 October 2012), Text.

doi.org

Gulevsky, Alexander Kirillovich; Abakumova, Yelena Sergeevna; Moiseyeva, Natalya Nikolaevna; Ivanov, Yevgeniy Gennadievich (2011). "Influence of Cord Blood Fraction (below 5 kDa) on Reparative Processes during Subchronic Ulcerative Gastropathy". Ulcers. 2011: 1–9. doi:10.1155/2011/214124.
Lee P, Nokes L, Smith PM (2012). "No effect of intravenous Actovegin® on peak aerobic capacity". Int J Sports Med. 33 (4): 305–9. doi:10.1055/s-0031-1291322. PMID 22318562. S2CID 2760688.
Lee, P.; Rattenberry, A.; Connelly, S.; Nokes, L. (2011). "Our Experience on Actovegin, is it Cutting Edge?". International Journal of Sports Medicine. 32 (4): 237–41. doi:10.1055/s-0030-1269862. PMID 21271496. S2CID 28641277.
Tsitsimpikou, Christina; Tsiokanos, Athanasios; Tsarouhas, Konstantinos; Schamasch, Patrick; Fitch, Kenneth D; Valasiadis, Dimitrios; Jamurtas, Athanasios (2009). "Medication Use by Athletes at the Athens 2004 Summer Olympic Games". Clinical Journal of Sport Medicine. 19 (1): 33–8. doi:10.1097/JSM.0b013e31818f169e. PMID 19124981. S2CID 40623178.
Ziegler, D.; Movsesyan, L.; Mankovsky, B.; Gurieva, I.; Abylaiuly, Z.; Strokov, I. (1997). "Treatment of Symptomatic Polyneuropathy With Actovegin in Type 2 Diabetic Patients". Diabetes Care. 33 (11): 1809–14. doi:10.2337/dc09-0545. PMC 2713653. PMID 9470838.
Derev'yannykh, E. A.; Bel'skaya, G. N.; Knoll, E. A.; Krylova, L. G.; Popov, D. V. (2008). "Experience in the use of actovegin in the treatment of patients with cognitive disorders in the acute period of stroke". Neuroscience and Behavioral Physiology. 38 (8): 873–5. doi:10.1007/s11055-008-9051-0. PMID 18802768. S2CID 8234398.
Guekht, A; Skoog, I; Edmundson, S; Zakharov, V; Korczyn, AD (2017). "ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment". Stroke. 48 (5): 1262–1270. doi:10.1161/STROKEAHA.116.014321. PMC 5404405. PMID 28432265.
Maillo, Luis (2008). "Anaphylactic Shock with Multiorgan Failure in a Cyclist after Intravenous Administration of Actovegin". Annals of Internal Medicine. 148 (5): 407. doi:10.7326/0003-4819-148-5-200803040-00022. PMID 18316765.
Reichl, F. X.; Högg, C.; Liu, F.; Schwarz, M.; Teupser, D.; Hickel, R.; Bloch, W.; Schweikl, H.; Thomas, P.; Summer, B. (July 2020). "Actovegin® reduces PMA-induced inflammation on human cells". European Journal of Applied Physiology. 120 (7): 1671–1680. doi:10.1007/s00421-020-04398-2. PMC 8497287. PMID 32447451.
Reichl, F. X.; Holdt, L. M.; Teupser, D.; Schütze, G.; Metcalfe, A. J.; Hickel, R.; Högg, C.; Bloch, W. (2017). "Comprehensive Analytics of Actovegin® and Its Effect on Muscle Cells". International Journal of Sports Medicine. 38 (11): 809–818. doi:10.1055/s-0043-115738. PMID 28895623.
Buchmayer F, Pleiner J, Elmlinger MW, Lauer G, Nell G, Sitte HH (2011). "Actovegin: a biological drug for more than 5 decades". Wien Med Wochenschr. 161 (3–4): 80–8. doi:10.1007/s10354-011-0865-y. PMID 21404144. S2CID 20989513.

espn.com

The doctor they call 'Healing Hans', ESPN, 2011-12-16.
Fish, Mike (December 16, 2011). "Anthony Galea receives no jail time". ESPN. Retrieved December 16, 2011.

latimes.com

companies (2016-04-18). "Fitness app Strava faces an uproar over an elite cycling user linked to doping". Los Angeles Times. Retrieved 2023-03-01.

newswire.com

"Actovegin And Other NYCOMED Products Called The Medicines Of The Year at PANACEA-2011". www.newswire.com (Press release). Retrieved 2023-03-06.

nih.gov

pubmed.ncbi.nlm.nih.gov

Lee P, Nokes L, Smith PM (2012). "No effect of intravenous Actovegin® on peak aerobic capacity". Int J Sports Med. 33 (4): 305–9. doi:10.1055/s-0031-1291322. PMID 22318562. S2CID 2760688.
Lee, P.; Rattenberry, A.; Connelly, S.; Nokes, L. (2011). "Our Experience on Actovegin, is it Cutting Edge?". International Journal of Sports Medicine. 32 (4): 237–41. doi:10.1055/s-0030-1269862. PMID 21271496. S2CID 28641277.
Tsitsimpikou, Christina; Tsiokanos, Athanasios; Tsarouhas, Konstantinos; Schamasch, Patrick; Fitch, Kenneth D; Valasiadis, Dimitrios; Jamurtas, Athanasios (2009). "Medication Use by Athletes at the Athens 2004 Summer Olympic Games". Clinical Journal of Sport Medicine. 19 (1): 33–8. doi:10.1097/JSM.0b013e31818f169e. PMID 19124981. S2CID 40623178.
Ziegler, D.; Movsesyan, L.; Mankovsky, B.; Gurieva, I.; Abylaiuly, Z.; Strokov, I. (1997). "Treatment of Symptomatic Polyneuropathy With Actovegin in Type 2 Diabetic Patients". Diabetes Care. 33 (11): 1809–14. doi:10.2337/dc09-0545. PMC 2713653. PMID 9470838.
Derev'yannykh, E. A.; Bel'skaya, G. N.; Knoll, E. A.; Krylova, L. G.; Popov, D. V. (2008). "Experience in the use of actovegin in the treatment of patients with cognitive disorders in the acute period of stroke". Neuroscience and Behavioral Physiology. 38 (8): 873–5. doi:10.1007/s11055-008-9051-0. PMID 18802768. S2CID 8234398.
Guekht, A; Skoog, I; Edmundson, S; Zakharov, V; Korczyn, AD (2017). "ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment". Stroke. 48 (5): 1262–1270. doi:10.1161/STROKEAHA.116.014321. PMC 5404405. PMID 28432265.
Maillo, Luis (2008). "Anaphylactic Shock with Multiorgan Failure in a Cyclist after Intravenous Administration of Actovegin". Annals of Internal Medicine. 148 (5): 407. doi:10.7326/0003-4819-148-5-200803040-00022. PMID 18316765.
Reichl, F. X.; Högg, C.; Liu, F.; Schwarz, M.; Teupser, D.; Hickel, R.; Bloch, W.; Schweikl, H.; Thomas, P.; Summer, B. (July 2020). "Actovegin® reduces PMA-induced inflammation on human cells". European Journal of Applied Physiology. 120 (7): 1671–1680. doi:10.1007/s00421-020-04398-2. PMC 8497287. PMID 32447451.
Reichl, F. X.; Holdt, L. M.; Teupser, D.; Schütze, G.; Metcalfe, A. J.; Hickel, R.; Högg, C.; Bloch, W. (2017). "Comprehensive Analytics of Actovegin® and Its Effect on Muscle Cells". International Journal of Sports Medicine. 38 (11): 809–818. doi:10.1055/s-0043-115738. PMID 28895623.
Buchmayer F, Pleiner J, Elmlinger MW, Lauer G, Nell G, Sitte HH (2011). "Actovegin: a biological drug for more than 5 decades". Wien Med Wochenschr. 161 (3–4): 80–8. doi:10.1007/s10354-011-0865-y. PMID 21404144. S2CID 20989513.

ncbi.nlm.nih.gov

Ziegler, D.; Movsesyan, L.; Mankovsky, B.; Gurieva, I.; Abylaiuly, Z.; Strokov, I. (1997). "Treatment of Symptomatic Polyneuropathy With Actovegin in Type 2 Diabetic Patients". Diabetes Care. 33 (11): 1809–14. doi:10.2337/dc09-0545. PMC 2713653. PMID 9470838.
Guekht, A; Skoog, I; Edmundson, S; Zakharov, V; Korczyn, AD (2017). "ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment". Stroke. 48 (5): 1262–1270. doi:10.1161/STROKEAHA.116.014321. PMC 5404405. PMID 28432265.
Reichl, F. X.; Högg, C.; Liu, F.; Schwarz, M.; Teupser, D.; Hickel, R.; Bloch, W.; Schweikl, H.; Thomas, P.; Summer, B. (July 2020). "Actovegin® reduces PMA-induced inflammation on human cells". European Journal of Applied Physiology. 120 (7): 1671–1680. doi:10.1007/s00421-020-04398-2. PMC 8497287. PMID 32447451.

nycomed.com

"Actovegin." Nycomed. 2011. Accessed 2011-09-16.

nydailynews.com

Canadian regulatory body suspends Dr. Anthony Galea for nine months following U.S. sports doping scandal, Daily News, 2017-12-06.

nytimes.com

Schmidt, Michael S.; Austen, Ian (2009-12-17). "Doctor Under Investigation Is Charged in Canada". The New York Times. Retrieved 2009-12-17.
Kovaleski, Serge. "Canadian Doctor Tied to Professional Athletes Guilty of Drug Charge." New York Times. July 6, 2011. Accessed 2011-09-16.

safemedicines.org

"Former Pro Cyclist Pleads Guilty Misbranded/Non FDA Approved Drug Importation". Partnership for Safe Medicines. 2016-03-24. Retrieved 2023-03-01.

semanticscholar.org

api.semanticscholar.org

Lee P, Nokes L, Smith PM (2012). "No effect of intravenous Actovegin® on peak aerobic capacity". Int J Sports Med. 33 (4): 305–9. doi:10.1055/s-0031-1291322. PMID 22318562. S2CID 2760688.
Lee, P.; Rattenberry, A.; Connelly, S.; Nokes, L. (2011). "Our Experience on Actovegin, is it Cutting Edge?". International Journal of Sports Medicine. 32 (4): 237–41. doi:10.1055/s-0030-1269862. PMID 21271496. S2CID 28641277.
Tsitsimpikou, Christina; Tsiokanos, Athanasios; Tsarouhas, Konstantinos; Schamasch, Patrick; Fitch, Kenneth D; Valasiadis, Dimitrios; Jamurtas, Athanasios (2009). "Medication Use by Athletes at the Athens 2004 Summer Olympic Games". Clinical Journal of Sport Medicine. 19 (1): 33–8. doi:10.1097/JSM.0b013e31818f169e. PMID 19124981. S2CID 40623178.
Derev'yannykh, E. A.; Bel'skaya, G. N.; Knoll, E. A.; Krylova, L. G.; Popov, D. V. (2008). "Experience in the use of actovegin in the treatment of patients with cognitive disorders in the acute period of stroke". Neuroscience and Behavioral Physiology. 38 (8): 873–5. doi:10.1007/s11055-008-9051-0. PMID 18802768. S2CID 8234398.
Buchmayer F, Pleiner J, Elmlinger MW, Lauer G, Nell G, Sitte HH (2011). "Actovegin: a biological drug for more than 5 decades". Wien Med Wochenschr. 161 (3–4): 80–8. doi:10.1007/s10354-011-0865-y. PMID 21404144. S2CID 20989513.

spiegel.de

Dopingfund in Göteborg, Polizei stellt Ermittlungen ein
Fiedler, Matthias (29 April 2021). "The eternal medicine man". Der Spiegel (in German).

thepharmaletter.com

"Nycomed May Invest 35 Million Euros in Ukrainian Production Capacities." The Pharma Letter. 3 May 2011. Accessed 2011-09-16.

webmd.com

Doheny, Kathleen. "FAQ on Actovegin: An Expert Explains How the Drug May Enhance Athletic Performance." WebMD Health News. December 16, 2009. Accessed 2011-09-16.